This App Can Diagnose Rare Diseases From a Child’s Face

Mar 8, 2022

WIRED

“FDNA, launched an app called Face2Gene. This app analyzes a face to suggest genetic disorders a person might have. Face2Gene is now used by thousands of geneticists worldwide. Its core algorithm can recognize about 300 disorders with high accuracy from a patient’s face. Last month, scientists from FDNA and several international institutions published results from a new algorithm called GestaltMatcher. It can distinguish about 1,000 conditions—a roughly threefold increase from FDNA’s original algorithm. It is now available in the Face2Gene app.”

 

Based on the article from WIRED, FDNA’s app, Face2Gene, is revolutionizing rare diseases to expedite diagnosis by analyzing a child’s facial features. This innovative app uses advanced AI algorithms to detect facial anomalies linked to rare genetic conditions. Recently, FDNA and international scientists introduced a new algorithm, GestaltMatcher, which increases the app’s capability to identify genetic conditions. This technology helps doctors in the early and precise identification of rare diseases, leading to timely interventions and personalized treatment plans.

Related articles

AI in genetic diagnosis

The Evolution of FDNA’s technology: An Interview with Aviram Bar Haim

Analyzing facial features has long been a vital step in diagnosing genetic syndromes. In recent years, AI-driven technologies have transformed this process, making it more efficient and accurate. Leading this innovation is Face2Gene, an advanced AI platform that leverages machine learning to assist clinicians in identifying genetic disorders. To explore the development of this groundbreaking […]

Continue reading
Genetic Research in Africa: An Interview

Genetic Research in Africa: An Interview with Dr. Aime Lumaka

Dr. Aime Lumaka, a distinguished geneticist from the Democratic Republic of Congo, is at the forefront of advancing genetic research across Africa. As a pivotal figure in the Deciphering Developmental Disorders in Africa (DDD-Africa) initiative and the Principal Investigator of the African Rare Diseases Initiative (ARDI), Dr Lumaka is leading efforts to evaluate clinical exome sequencing in […]

Continue reading